MENU
NAGE
AS OF
Feb 4, 04:12 PM (EDT)
Price
$5.58
Change
-$0.11 (-1.94%)
Capitalization
453.3M
35 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
NAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Niagen Bioscience (NAGE) Ownership - Who owns Niagen Bioscience?

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
453.3M
P/E Ratio
23.67
Total Cash
64.14M
Projected Growth
N/A
Total Debt
3.06M
Revenue
124.71M
Risk (Beta)
2.85
Dividend Yield
N/A
Total Cash/Share
0.80
Total Debt/Equity
N/A
Revenue/Share
1.47 USD as % of share price

Fundamentals

NAGE
Capitalization
453M
P/E Ratio
23.67
Risk (Beta)
2.85
Dividend Yield
N/A
Total Cash
64.1M
Total Cash/Share
0.80
Total Debt
3.06M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.47%
Revenue
125M
ROE
N/A
Book Value
70.7M
P/B Ratio
6.41
Cash Flow
N/A
Earnings
0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
79K
Current Ratio
4.12
Current Revenue Per Employee
326788.47
Dividends Per Share - Security
N/A
EBITDA
20.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
64.52
Revenue To Assets
26.42
Shares Held By Institutions
392M
Shares Outstanding - Current
79.8M
Total Liabilities
27.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.770
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NAGE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAGE showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NAGE
A.I. Advisor
published General Information

General Information

a developer of proprietary-based ingredient technologies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A